ASCO 2024 brought together thousands of minds and voices in oncology and life sciences. We captured the essence of these conversations to highlight pivotal moments and trends that defined the event. From groundbreaking research to inspiring stories, see what everyone was talking about online. Get our social listening report: https://lnkd.in/e4yi8_8Y #ASCO2024 #oncology #lifesciences #insights
Precision AQ’s Post
More Relevant Posts
-
Why is a robust data management system so important for early phase #oncology research? Read the latest edition of Medrio’s Trial Talks to learn: 💡 How the evolving landscape of oncology research is driving innovation. 📲 Why your data capture strategy needs the right technology foundation. 🎯 What to look for in a CDMS/EDC system for early phase oncology. Read More: https://bit.ly/3SJ2d3j #ClinicalTrials #CDMS #EDC #DataManagement #ClinicalDataManagement
-
-
Delve into our latest case study: "𝗘𝗹𝗲𝘃𝗮𝘁𝗶𝗻𝗴 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 𝗕𝗿𝗮𝗻𝗱 𝗘𝘅𝗰𝗲𝗹𝗹𝗲𝗻𝗰𝗲: 𝗔 𝗖𝘂𝘀𝘁𝗼𝗺𝗲𝗿-𝗖𝗲𝗻𝘁𝗿𝗶𝗰 𝗔𝘀𝘀𝗲𝘀𝘀𝗺𝗲𝗻𝘁 𝗔𝗺𝗼𝗻𝗴 𝗦𝗶𝗻𝗴𝗮𝗽𝗼𝗿𝗲𝗮𝗻 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝗶𝘀𝘁𝘀." Explore how we're reshaping oncology brand strategies with a customer-centric approach. Join us as we reveal insights from 𝗦𝗶𝗻𝗴𝗮𝗽𝗼𝗿𝗲𝗮𝗻 𝗼𝗻𝗰𝗼𝗹𝗼𝗴𝗶𝘀𝘁𝘀, influencing the future of oncology brand excellence. #Oncology #BrandExcellence #CustomerCentricity #oncologist
-
It’s the first anniversary of BMJ Oncology 🎉Thank you to all our authors, reviewers, editorial board members, statistical editors, patients and series advisors and readers. Read our most popular content: https://bit.ly/3V6K9TC #Oncology #BMJOncology
-
-
The HiRO GO model is more than a strategy; it’s a paradigm shift. By harmonizing the strengths of the APAC region, HiRO offers a cohesive, streamlined approach to oncology trials that encompasses expert local knowledge and global reach. Learn more in our detailed blog. https://lnkd.in/gdmT8jrq #ClinicalTrials #Oncology #HiRO
-
-
Tumor-seeking radiopharmaceuticals are charting a new course in #oncology, with promise for targeted treatments with fewer side effects. Learn more in this article by Elie Dolgin, originally published in Knowable Magazine: https://lnkd.in/ekmqKM6s.
-
Aster Insights drives smarter decision-making in #oncology discovery and development. Explore our scientific publications to learn how we generate novel insights that power oncology breakthroughs: https://ow.ly/Z55P50POBBu #PrecisionMedicine #OncologyResearch
-
-
📅 Just a few weeks left to register: Our #oncology and #eCOA experts discuss the very latest science on and offer practical tips for leveraging PROMs throughout oncology #drugdevelopment. Sign up for free: https://bit.ly/47mhvQZ #webinar #oncologytrials #ePRO #eCOA #lifesciences
-
-
📅 Just a few weeks left to register: Our #oncology and #eCOA experts discuss the very latest science on and offer practical tips for leveraging PROMs throughout oncology #drugdevelopment. Sign up for free: https://bit.ly/47mhvQZ #webinar #oncologytrials #ePRO #eCOA #lifesciences
-
-
“By standardizing tissue quality, both false positives and negatives can be minimized. This helps ensure the reliability of findings in biomarker-based discovery, patient stratification and treatment identification. Thus, starting with high quality tissue is crucial in protecting investments in resources and time, and most importantly patient lives.” Our Senior Director Oncology Analytics, Dr. Daniel Pohlmann, provided insights into our workflow and how we are ensuring the standardized collection of high quality tissue to optimize drug discovery in an article from Labiotech.eu titled “Standardizing tissue quality: Your key to accurate early discovery insights.” View the full article: https://bit.ly/3GDB9Ni #BeyondGenomics #Oncology #CancerResearch
-
-
📅 Just a few weeks left to register: Our #oncology and #eCOA experts discuss the very latest science on and offer practical tips for leveraging PROMs throughout oncology #drugdevelopment. Sign up for free: https://bit.ly/47mhvQZ #webinar #oncologytrials #ePRO #eCOA #lifesciences
-
